跳至主要内容
临床试验/NCT01167829
NCT01167829已完成1 期

Pharmacokinetics of Modified Slow-Release Oral Testosterone Over 10 Days in Normal Men With Experimental Hypogonadism

University of Washington1 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2010年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
14
试验地点
1
主要终点
Maximum Testosterone Concentration

研究概览

简要总结

The purpose of this study is to test how the body absorbs a new form of oral testosterone (T). On Day 1 and Day 9 there are overnight stays in the General Clinical Research Center at the University of Washington to monitor blood testosterone levels over a 24-hour period.

详细描述

We will administer two experimental drugs, acyline and oral testosterone. Acyline shots will be given on Day 0 to turn off the body's testosterone production for about 10-14 days.

The next day, Day 1, subjects begin taking 300 mg modified slow-release testosterone pill by mouth, three times a day, around 9 AM, 1 PM, and 7 PM for a total of 27 pills.

There are overnight stays on Day 1 and Day 9 to allow monitoring of blood testosterone levels over a 24 hour period, from @9 AM to 9 AM the next morning. At those visits, blood is drawn at baseline (before taking the pill) and at 1, 2, 4, 5, 6, 8, 10, 11, 12, 14, 16, and 24 hours after the morning dose.

Acyline is an experimental drug. The FDA allows its use only in research with a small number of volunteers. We have used acyline in over 125 men without serious side effects. The use of testosterone in this study is experimental and there may be unknown or unanticipated risks.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Acyline and oral testosterone

Experimental

干预措施: Oral Testosterone (Drug)

Acyline and oral testosterone

Experimental

干预措施: Acyline (Drug)

结局指标

主要结局

Maximum Testosterone Concentration

时间窗: baseline & day 9

initial pharmacokinetics \[PK\] (day 1) of oral testosterone dosed 3 times daily and the PK after 9 days of treatment

Mean Testosterone Concentration

时间窗: baseline & day 9

initial 24-hour pharmacokinetics (PK) of oral testosterone dosed 3 times daily and post 24-hour PK after 9 days of treatment

次要结局

  • Maximum Dihydrotestosterone (DHT) Concentration(baseline & day 9)
  • Mean Dihydrotestosterone (DHT) Concentration(baseline & day 9)
  • Maximum Sex Hormone-Binding Globulin (SHGB)Concentration(baseline & day 9)
  • Mean SHGB Concentration(baseline & day 9)
  • Maximum Estradiol Concentration(baseline & day 9)
  • Mean Estradiol Concentration(baseline & day 9)
  • Free T Maximum Concentration(baseline & day 9)
  • Free Testosterone Mean Concentration(baseline & day 9)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

John Amory

Professor

University of Washington

研究点 (1)

Loading locations...

相似试验

ORAL T-8 Oral Testosterone for Male Hormonal... | 临床试验